Navigation Links
U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks
Date:6/23/2008

Prevention Expert Offers Tips for Benefits/HR Managers

DALLAS, June 23 /PRNewswire/ -- Employers and their corporate human resources departments can play an important role in preventing their workers from suffering crippling or fatal heart attacks, according to a leading prevention expert at U.S. Preventive Medicine, the leader in disease prevention.

Dr. Boyd Lyles, corporate medical director at U.S. Preventive Medicine, says it's not uncommon for heart attacks to strike individuals who seem relatively healthy or who feel good. "Unfortunately, people, by nature, do not seek out medical care when they don't feel bad. They don't want the possibility of getting bad news or to be told that they should be doing things that they don't want to do, such as eating differently, drinking less alcohol, not smoking, or exercising more regularly," says Dr. Lyles.

With employer health care costs continuing to rise at nearly double digit increases, prevention and wellness programs in the workplace are beginning to gain much more attention, noted Dr. Lyles.

"We are committed to helping employers make prevention their top priority when it comes to the health of their employees and families," says Dr. Lyles. "In a climate of increasing costs of living, including health insurance and co-pays for physician visits and medications, it is important to spend money wisely. A little reading or study can prove very helpful in making informed decisions about their health."

Dr. Lyles offers these suggestions for employers:

1) Provide a proactive, thorough, employee-friendly portal to preventive health care that eliminates the confusion about what and when to do to be truly preventive. This should include health risk assessments (HRAs), lifestyle/behavior education opportunities, as well as guidance for the appropriate medical testing. Health coaching, either by telephone or internet can be very effective.

2) Install a "library" that
'/>"/>

SOURCE U.S. Prevention Medicine
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
2. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
4. Alabama Hospitals Compare Infection Prevention Performance Statewide With New Benchmarking Tool
5. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
6. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
7. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
10. Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack
11. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... report is available in its catalogue: ... and Technologies for Advanced Drug Delivery ... Administration http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... the Program in Cellular and Molecular Medicine at Boston ... (PCMM/IDI) have developed a molecular delivery platform that overcomes one ... to treat cancer: Making sure the treatment gets to the ... Lieberman , PhD, of the PCMM/IDI, and a former fellow ...
... company committed to the development of new epilepsy treatments ... data at the 64th Annual Meeting of the American ... 21-28.  The data comprise several posters examining the use ... updated health-related quality of life analysis from pooled open ...
Cached Medicine Technology:Packaging therapeutic RNAs for targeted treatment of breast cancer 2Packaging therapeutic RNAs for targeted treatment of breast cancer 3Packaging therapeutic RNAs for targeted treatment of breast cancer 4UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 2UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 3UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 4UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 5UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 6UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 7UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 8UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology 9
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit organization ... published a comprehensive review today examining the current state ... The review calls for improved global surveillance strategies to ... recent outbreak of Ebola in West Africa that has ... of Guinea and Liberia. According to the World ...
(Date:4/17/2014)... research team led by Cesar A. Arias, M.D., Ph.D., ... Houston (UTHealth) has identified a new superbug that caused ... appeared in the April 17 issue of The ... superbug is part of a class of highly-resistant bacteria ... which is a major cause of hospital and community-associated ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:New MRSA superbug emerges in Brazil 2
... predictive models of human disease is likely following ... (ESF), which urged for a collaborative effort between ... an enormous amount of data from different sources ... of human tissue, and in vitro laboratory experiments. ...
... WASHINGTON, Nov. 12 The Service Employees,International Union (SEIU), ... the following statement in support of the diagnosis of,and ... by,Senator Max Baucus (D-MT) today:, On the heels ... their top overall issues -- and health care costs ...
... as Rainmakers, SAN DIEGO, Nov. 12 New ... of nurses as hospital revenue,generators, according to a new ... staffing company in,the nation, the survey of 305 hospital ... and the emerging role of nurses as,financial rainmakers., ...
... Pharmaceuticals Inc.,announces the promotion of William N. ... Orthopaedics and Urology Business Unit, recently formed ... formerly Executive Director of,Ferring,s Orthopaedics Business Unit., ... In his new role, Garbarini is responsible ...
... components will feature its productivity maximizing products at ASCB Meeting in San ... ... 2008 -- InVitria InVitria announced today that it will showcase ... Biology Meeting on Dec. 13-17 in San Francisco, CA. InVitria provides animal ...
... record lows,the nation,s stress level hits record highs, but despite ... being more stressed,than ever. In his latest book, Life from ... advice such as, "don,t worry, just,stay calm," not only doesn,t ... problem is explained by new information on the nature of ...
Cached Medicine News:Health News:Computers make sense of experiments on human disease 2Health News:Computers make sense of experiments on human disease 3Health News:SEIU Statement in Support of New Blueprint to Solve Health Care Crisis by Senator Max Baucus 2Health News:AMN Survey: Nurses to Have Bigger Impact on Hospital Revenue 2Health News:Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit 2Health News:Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit 3Health News:InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting 2Health News:InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting 3Health News:Stress Spikes as Economy Tanks - Psychologist Identifies Why Traditional 'Stress Management' Techniques Don't Work, and Offers Radical New Approach 2
Pilling-Weck, medium clip size, 10mm, rotatable take apart...
Insert only, Ethicon, small clip size...
Ethicon, medium clip size, 10mm, rotatable take apart...
... The Wako CRP-HS assay utilizes turbidimetric ... procedure, measuring over the range of 0.2-28.0 ... can be adapted to most clinical chemistry ... performance in terms of precision, linearity, correlation, ...
Medicine Products: